Advent Pharma Ltd. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was BDT 151.66 million compared to BDT 151.31 million a year ago. Net income was BDT 32.27 million compared to BDT 37.72 million a year ago.

Basic earnings per share from continuing operations was BDT 0.35 compared to BDT 0.41 a year ago.